• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Brief video intervention to improve attitudes throughout medications for opioid use disorder in a correctional setting.简短的视频干预措施可改善监管场所阿片类药物使用障碍药物治疗期间的态度。
J Subst Abuse Treat. 2019 Sep;104:28-33. doi: 10.1016/j.jsat.2019.06.001. Epub 2019 Jun 10.
2
Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.扩大监狱中阿片类药物使用障碍(MOUD)药物的获取途径:一项综合项目评估。
J Subst Use Addict Treat. 2024 Jun;161:209248. doi: 10.1016/j.josat.2023.209248. Epub 2023 Dec 9.
3
Post-incarceration outcomes of a comprehensive statewide correctional MOUD program: a retrospective cohort study.一项全州范围综合性惩教药物维持治疗计划的监禁后结果:一项回顾性队列研究。
Lancet Reg Health Am. 2022 Dec 23;18:100419. doi: 10.1016/j.lana.2022.100419. eCollection 2023 Feb.
4
Medications for opioid use disorder in state prisons: Perspectives of formerly incarcerated persons.州立监狱中阿片类药物使用障碍的药物治疗:曾被监禁者的观点。
Subst Abus. 2022;43(1):964-971. doi: 10.1080/08897077.2022.2060448.
5
An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.对被监禁者阿片类药物使用障碍(MOUD)药物治疗的伦理分析。
Subst Abus. 2020;41(2):150-154. doi: 10.1080/08897077.2019.1695706. Epub 2019 Dec 4.
6
Treatment preference for opioid use disorder among people who are incarcerated.监禁人群中阿片类药物使用障碍的治疗偏好。
J Subst Abuse Treat. 2022 Jun;137:108690. doi: 10.1016/j.jsat.2021.108690. Epub 2021 Dec 13.
7
The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose.在全州范围内的惩教系统中实施阿片类药物使用障碍治疗药物和 COVID-19 对治疗参与度、释放后继续治疗和药物过量的影响。
J Subst Use Addict Treat. 2023 Sep;152:209103. doi: 10.1016/j.josat.2023.209103. Epub 2023 Jun 11.
8
Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.美国监禁孕妇阿片类药物使用障碍发生率和治疗情况:一项全国性监测研究结果。
Addiction. 2020 Nov;115(11):2057-2065. doi: 10.1111/add.15030. Epub 2020 Mar 18.
9
COVID-19 and treating incarcerated populations for opioid use disorder.COVID-19 与治疗监禁人群中的阿片类药物使用障碍
J Subst Abuse Treat. 2021 May;124:108216. doi: 10.1016/j.jsat.2020.108216. Epub 2020 Dec 2.
10
Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: A retrospective cohort study.阿片类物质使用障碍的监狱内药物治疗与社区持续治疗之间的照护过渡:一项回顾性队列研究。
Drug Alcohol Depend. 2024 Aug 1;261:111377. doi: 10.1016/j.drugalcdep.2024.111377. Epub 2024 Jun 24.

引用本文的文献

1
Assessing the comparative effectiveness of ECHO and coaching implementation strategies in a jail/provider MOUD implementation trial.在一项监狱/提供者药物辅助治疗(MOUD)实施试验中评估ECHO和指导实施策略的比较效果。
Implement Sci. 2025 Feb 3;20(1):7. doi: 10.1186/s13012-025-01419-6.
2
The effect of a pilot brief educational intervention on preferences regarding treatments for opioid use disorder.一项试点简短教育干预对阿片类物质使用障碍治疗偏好的影响。
Drug Alcohol Depend Rep. 2024 Apr 24;11:100235. doi: 10.1016/j.dadr.2024.100235. eCollection 2024 Jun.
3
Evaluation of Two Videos that Apply Evidence-Based Strategies to Increase Self-Efficacy and Reduce Opioid-Related Stigma Among Medical Students.评估两段应用循证策略的视频,以提高医学生的自我效能感并减少与阿片类药物相关的耻辱感。
Acad Psychiatry. 2024 Apr;48(2):123-134. doi: 10.1007/s40596-024-01945-3. Epub 2024 Feb 22.
4
Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone.接受美沙酮治疗的患者中基于医疗保健和药物使用治疗提供者的污名化经历。
Drug Alcohol Depend Rep. 2023 Feb 7;6:100138. doi: 10.1016/j.dadr.2023.100138. eCollection 2023 Mar.
5
A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration.一项针对 Veterans Health Administration 中涉及法律问题的退伍军人中阿片类药物使用障碍药物治疗的障碍和促进因素的全国性调查。
Subst Abus. 2022;43(1):556-563. doi: 10.1080/08897077.2021.1975867. Epub 2021 Sep 29.
6
Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study.提高法律体系内退伍军人阿片类药物使用障碍药物治疗实施率的策略:一项定性研究。
J Subst Abuse Treat. 2021 Oct;129:108353. doi: 10.1016/j.jsat.2021.108353. Epub 2021 Mar 4.
7
Fostering MOUD use in justice populations: Assessing the comparative effectiveness of two favored implementation strategies to increase MOUD use.促进司法人群使用美沙酮维持治疗:评估两种增加美沙酮维持治疗使用的首选实施策略的相对效果。
J Subst Abuse Treat. 2021 Sep;128:108370. doi: 10.1016/j.jsat.2021.108370. Epub 2021 Mar 17.
8
Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study.优化出狱和监狱环境中阿片类药物使用障碍药物的影响:一项微观模拟建模研究。
Int J Drug Policy. 2021 May;91:102841. doi: 10.1016/j.drugpo.2020.102841. Epub 2020 Jul 22.
9
Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders.与用于阿片类物质使用障碍的短效药物相比,对长效注射剂和植入式药物的认知及偏好。
J Subst Abuse Treat. 2020 Apr;111:54-66. doi: 10.1016/j.jsat.2020.01.009. Epub 2020 Jan 21.

本文引用的文献

1
The First Comprehensive Program for Opioid Use Disorder in a US Statewide Correctional System.美国全州惩教系统首个阿片类药物使用障碍综合项目。
Am J Public Health. 2018 Oct;108(10):1323-1325. doi: 10.2105/AJPH.2018.304666.
2
Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System.在全州监狱系统实施药物成瘾治疗后,监禁后的致命过量。
JAMA Psychiatry. 2018 Apr 1;75(4):405-407. doi: 10.1001/jamapsychiatry.2017.4614.
3
A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.一项美监狱和看守所中美沙酮维持治疗与强制脱毒随机、开放标签试验:释放后 12 个月的结果。
Drug Alcohol Depend. 2018 Mar 1;184:57-63. doi: 10.1016/j.drugalcdep.2017.11.023. Epub 2018 Jan 31.
4
Making sense of Cronbach's alpha.理解克朗巴哈系数。
Int J Med Educ. 2011 Jun 27;2:53-55. doi: 10.5116/ijme.4dfb.8dfd.
5
Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions.监狱中阿片类药物依赖的药物治疗:研究综述更新与未来方向
Subst Abuse Rehabil. 2016 Apr 27;7:27-40. doi: 10.2147/SAR.S81602. eCollection 2016.
6
Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification.患者对药物的信念与住院阿片类药物脱毒后对美沙酮、丁丙诺啡、纳曲酮或不进行药物辅助治疗的明确偏好相关。
J Subst Abuse Treat. 2016 Jul;66:48-53. doi: 10.1016/j.jsat.2016.02.009. Epub 2016 Mar 9.
7
The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings.躯体治疗协作组:美国国立药物滥用研究所关于刑事司法环境中阿片类药物治疗药物疗法的合作研究介绍。
Contemp Clin Trials. 2016 May;48:166-72. doi: 10.1016/j.cct.2016.05.003. Epub 2016 May 11.
8
Accessing methadone within Moldovan prisons: Prejudice and myths amplified by peers.摩尔多瓦监狱内获取美沙酮的情况:同伴加剧的偏见与误解
Int J Drug Policy. 2016 Mar;29:91-5. doi: 10.1016/j.drugpo.2015.12.016. Epub 2015 Dec 23.
9
Experienced and anticipated discrimination reported by individuals in treatment for substance use disorders within the Netherlands.荷兰接受物质使用障碍治疗的个体报告的经历过的和预期的歧视。
Health Soc Care Community. 2016 Sep;24(5):e23-33. doi: 10.1111/hsc.12279. Epub 2015 Sep 28.
10
Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS.在乌克兰监狱实施阿片类药物替代疗法面临的挑战:工作人员对成瘾、治疗以及艾滋病毒/艾滋病感染者的态度。
Drug Alcohol Depend. 2015 Mar 1;148:47-55. doi: 10.1016/j.drugalcdep.2014.12.008. Epub 2014 Dec 22.

简短的视频干预措施可改善监管场所阿片类药物使用障碍药物治疗期间的态度。

Brief video intervention to improve attitudes throughout medications for opioid use disorder in a correctional setting.

机构信息

Warren Alpert Medical School, Brown University, Providence, RI, United States of America.

Harvard Department of Psychology, Harvard University, Cambridge, MA, United States of America.

出版信息

J Subst Abuse Treat. 2019 Sep;104:28-33. doi: 10.1016/j.jsat.2019.06.001. Epub 2019 Jun 10.

DOI:10.1016/j.jsat.2019.06.001
PMID:31370982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6684325/
Abstract

OBJECTIVES

Medications for opioid use disorder (MOUD) in the criminal justice setting is an effective way to address opioid use disorder and prevent associated deaths in the community. The Rhode Island Department of Corrections (RIDOC) is the first statewide correctional system in the United States to offer comprehensive MOUD services to incarcerated individuals.However, due to stigma, eligible individuals may be reluctant to engage with MOUD. This study aims to 1) evaluate the efficacy of an educational video intervention about MOUD and 2) characterize MOUD-related attitudes in a general incarcerated population.

METHODS

Participants were recruited from eight elective classes offered to soon-to-be-released incarcerated individuals at RIDOC. Participants viewed an eight-minute video featuring incarcerated individuals speaking about their experiences using MOUD, designed to reduce MOUD-related stigma. Participants were administered surveys prior to and after watching the video to assess changes in MOUD knowledge (MOUD-K) and MOUD attitudes (MOUD-A).

RESULTS

This evaluation of the intervention included 80 incarcerated participants (median age = 35, 93% male, 36% non-Hispanic White, and 26% non-Hispanic Black). Forty percent indicated non-medical opioid use within six months prior to incarceration; 13% had previously used MOUD. Significant improvements in MOUD-K scores (t(65) = -7.0, p < 0.0001) and MOUD-A scores (t(69) = -5.8, p < 0.0001) were detected after participants viewed the video. The intervention yielded greater ΔMOUD-A scores among those identifying as non-Hispanic Black, compared to non-Hispanic Whites (β = 2.6, CI = 0.4, 4.8).

CONCLUSION

The educational video improved both knowledge and positive attitudes towards MOUD, with changes in MOUD attitudes being influenced by race. These findings may inform future MOUD educational programs, thereby helping to reduce opioid use disorder-related morbidity and mortality.

摘要

目的

在刑事司法环境中,治疗阿片类药物使用障碍(MOUD)的药物是解决阿片类药物使用障碍和预防社区相关死亡的有效方法。罗得岛惩教署(RIDOC)是美国第一个为被监禁个人提供全面 MOUD 服务的全州惩教系统。然而,由于耻辱感,符合条件的个人可能不愿意接受 MOUD。本研究旨在 1)评估关于 MOUD 的教育视频干预的效果,2)描述一般监禁人群中与 MOUD 相关的态度。

方法

参与者从 RIDOC 向即将获释的被监禁个人提供的八门选修课程中招募。参与者观看了一段八分钟的视频,视频中介绍了一些被监禁的个人讲述他们使用 MOUD 的经验,旨在减少 MOUD 相关的耻辱感。在观看视频前后,参与者接受了调查,以评估 MOUD 知识(MOUD-K)和 MOUD 态度(MOUD-A)的变化。

结果

这项干预措施的评估包括 80 名被监禁的参与者(中位数年龄为 35 岁,93%为男性,36%为非西班牙裔白人,26%为非西班牙裔黑人)。40%的人表示在入狱前六个月内曾有非医疗性阿片类药物使用;13%的人曾使用过 MOUD。参与者观看视频后,MOUD-K 评分(t(65)=-7.0,p<0.0001)和 MOUD-A 评分(t(69)=-5.8,p<0.0001)均显著提高。与非西班牙裔白人相比,黑人参与者的 MOUD-A 评分变化更大(β=2.6,CI=0.4,4.8)。

结论

教育视频提高了对 MOUD 的知识和积极态度,MOUD 态度的变化受到种族的影响。这些发现可能为未来的 MOUD 教育项目提供信息,从而有助于降低阿片类药物使用障碍相关的发病率和死亡率。